A healthy side effect of diabetes drug

September 23, 2013, Monash University
Dr Dear said the drugs potential was important, as Type 2 diabetics often had poor cardiovascular health. Credit: iStock

(Medical Xpress)—New research has shown the promising potential of a glucose-regulating drug to improve the condition of arteries for diabetes sufferers, possibly protecting them against heart attack or stroke.

Dr Anthony Dear and Professor Richard Simpson from Monash University's Eastern Clinical Research Unit are leading a research team, who for several years have been investigating the beneficial side effect of the a new glucose-regulating medication.

A pre-clinical study, published in the journal Diabetes and Vascular Disease Research, demonstrated potentially beneficial effects of the drug in improving or stabilising diabetic vascular disease.

Dr Dear said the drug's potential was important, as Type 2 diabetics often had poor cardiovascular health.

"As the of diabetes escalates, this drug has the potential to offer tremendous help to millions of diabetics worldwide," Dr Dear said.

"Pre-clinical studies suggest the drug may improve in Type 2 diabetics. We think it may have the potential to reduce heart attacks and strokes in those diabetics whose cardiovascular systems are damaged due to the disease.

"Lots of drugs lower blood sugar but they don't necessarily protect blood vessels."

Dr Dear said the drug was derived from the natural gut hormone, Glucagon-Like Peptide-1 (GLP-1).

"It effectively lowers by stimulating in the body. It is a derivative of a naturally-occurring substance which appears to have receptors for it on the surface of in addition to the pancreas, suggesting it may also have an effect on ," Dr Dear said.

"We think it may also 'smooth' the surface of and make them less sticky and prone to develop 'blockages' - a condition frequently seen in Type 2 diabetics. This would mean that blockages, often contributing to the cause of heart attacks and strokes, would be less likely to form."

Dr Dear said the drug might have the extra potential to improve some of the challenges experienced by diabetics, including weight loss.

"One of the effects of the drug, and natural hormone from which the drug is derived, is to cause weight loss," Dr Dear said.

"Its benefits outside of lowering blood-sugar levels are conducive to problems that diabetics may have, such as being overweight or accelerated blood vessel disease."

The research is being conducted by the Eastern Clinical Research Unit, Translational Research Division at Monash in collaboration with the University's Department of Pharmacology.

The World Health Organisation reports that more that more than 347 million people worldwide live with diabetes and around 90 per cent of these cases are Type 2.

Explore further: Gout drug shown to benefit diabetes patients at risk of heart disease

More information: dvr.sagepub.com/content/early/ … 64113481817.full.pdf

Related Stories

Gout drug shown to benefit diabetes patients at risk of heart disease

August 29, 2013
New research carried out at the University of Dundee has led to the possibility of using an old drug to help prevent the biggest cause of death in Type II diabetes patients.

Short-term blood sugar control in patients with diabetes has limited effect on risk of cardiovascular problems

September 3, 2013
(Medical Xpress)—An international study has shown that short-term blood sugar control in patients with diabetes has a limited effect on their risk of cardiovascular problems, such as heart disease and stroke.

Cardiovascular risk in type 2 diabetics with dangerously low blood sugar levels

July 30, 2013
Type 2 diabetics who have severe hypoglycaemia are at higher risk of cardiovascular disease, a paper published today in BMJ suggests.

Diabetes drug may reduce brain damage after stroke

December 3, 2012
In a study in mice, scientists at Karolinska Institutet in Sweden have discovered a new potential therapy that may reduce brain damage following stroke in type 2 diabetic patients. The suggested drug is already approved for ...

Pain reliever lowers blood sugar in type 2 diabetics, study says

July 1, 2013
(HealthDay)— An aspirin-like drug appears to lower blood sugar in people with type 2 diabetes, according to new research.

Natural, edible treatment offers promise for diabetics

June 28, 2013
A potentially revolutionary treatment for diabetics mimics the benefits of major surgery, but achieves the same results without it.

Recommended for you

Genetic discovery may help better identify children at risk for type 1 diabetes

January 17, 2018
Six novel chromosomal regions identified by scientists leading a large, prospective study of children at risk for type 1 diabetes will enable the discovery of more genes that cause the disease and more targets for treating ...

Women who have gestational diabetes in pregnancy are at higher risk of future health issues

January 16, 2018
Women who have gestational diabetes mellitus (GDM) during pregnancy have a higher than usual risk of developing type 2 diabetes, hypertension, and ischemic heart disease in the future, according to new research led by the ...

Diabetes gene found that causes low and high blood sugar levels in the same family

January 15, 2018
A study of families with rare blood sugar conditions has revealed a new gene thought to be critical in the regulation of insulin, the key hormone in diabetes.

Discovery could lead to new therapies for diabetics

January 12, 2018
New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy ...

Enzyme shown to regulate inflammation and metabolism in fat tissue

January 11, 2018
The human body has two primary kinds of fat—white fat, which stores excess calories and is associated with obesity, and brown fat, which burns calories in order to produce heat and has garnered interest as a potential means ...

Big strides made in diabetes care

January 5, 2018
(HealthDay)—This past year was a busy, productive one for diabetes research and care.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.